Opens in a new tab

Dr. Chen Yanming

Chinese name: 陈燕铭
Professor, Chief Physician, Doctoral Supervisor, Vice President . Endocrinology & Metabolism
Professor Chen Yanming is Vice President of the Third Affiliated Hospital of Sun Yat-sen University and academic leader of endocrinology and metabolism. She directs the Sun Yat-sen University Diabetes Institute and specialises in diabetes and its complications, thyroid disease and pituitary-adrenal disorders, with a focus on stem cell and immunomodulatory therapy for diabetes.

Private & confidential

No obligation

Coordinated end-to-end by Orisene

nearly 30
Years in endocrinology practice
80+
Peer-reviewed publications
8
Software copyright patents

  • The Physician

About Dr. Chen Yanming

Professor Chen Yanming is Vice President of the Third Affiliated Hospital of Sun Yat-sen University, academic leader of endocrinology and metabolism, and Director of the Sun Yat-sen University Diabetes Institute and the Guangdong Key Laboratory for Diabetes Prevention and Treatment. She has devoted nearly thirty years to endocrine and metabolic disease, specialising in diabetes and its complications, thyroid disorders and pituitary-adrenal disease. Her research focuses on the immunology of type 1 diabetes and stem cell therapy, and she has led national and provincial research projects. She has published more than eighty papers and holds several national software patents.
1、Vice President of the Third Affiliated Hospital of Sun Yat-sen University
2、Academic leader of endocrinology and metabolism
3、Director of the Sun Yat-sen University Diabetes Institute and the Guangdong Key Laboratory for Diabetes Prevention and Treatment
4、President of the Eighth Affiliated Hospital of Sun Yat-sen University
5、Vice Chairman of the Youth Committee of the Chinese Society of Endocrinology
6、Recipient of a provincial science and technology award for diabetes research

Dr. Chen Yanming ’s Three Key Areas of Expertise

Three areas of focused expertise, each supported by a deep subspecialty team, high case volumes and an English-speaking care pathway coordinated by Orisene.

Diabetes and its complications

She diagnoses and treats type 1 and type 2 diabetes, individualising insulin, oral and incretin-based therapy to control blood glucose, prevent cardiovascular, kidney, eye and nerve complications and improve the long-term health and quality of life of patients living with diabetes.

Thyroid disease

She manages hyperthyroidism, hypothyroidism, thyroid nodules and thyroid disease in pregnancy, integrating laboratory testing, thyroid ultrasound and individualised medical treatment to restore normal thyroid function and address the concerns of patients living with these common and often complex endocrine disorders.

Pituitary and adrenal disorders

She diagnoses and treats pituitary tumours, acromegaly, Cushing's syndrome and adrenal disease, using detailed hormonal testing and imaging to identify rare endocrine causes and design precise, individualised medical or surgical treatment plans for patients living with these complex hormonal disorders.

More： obesity——weight management; osteoporosis——treatment; metabolic syndrome——management; diabetic foot——prevention; gestational diabetes——care

  • Clinical Practice & Publications

Selected cases, research & publications

Representative work drawn from documented clinical treatments, publicly indexed literature, and hospital project records, reflecting the depth of this physician's hands-on expertise and academic rigor.
1. Human Gingiva-Derived Mesenchymal Stem Cells for Type 1 Diabetes: Phase 1 Trial
This double-blind, randomized, placebo-controlled phase 1 trial tested intravenous human gingiva-derived mesenchymal stem cells in patients with type 1 diabetes. The therapy was safe and improved residual beta-cell function, with one participant stopping exogenous insulin while maintaining good glucose control during follow-up.
2. CCL2-Positive Adipose-Derived Stem Cells Promote Diabetic Wound Healing
Single-cell sequencing revealed that CCL2-positive adipose-derived stem cells promote diabetic wound healing through the CCL2-ACKR1 signaling axis. The findings offer a potential cell-based treatment to accelerate healing of chronic foot ulcers in patients with diabetes and reduce amputation risk in high-risk individuals.
3. Bioactive Hydrogel for Diabetic Wound Healing
This study developed a bioactive hydrogel using plant exosome-like nanovesicles that enhance macrophage efferocytosis to promote healing of diabetic wounds. The approach represents a new dressing strategy for patients with slow-healing diabetic foot ulcers and chronic non-healing skin lesions in clinical wound care.
4. cGAS-STING Signaling in Retinal Vascular Homeostasis and Angiogenesis
This cross-species atlas mapped cGAS-STING signaling in pathophysiological angiogenesis and retinal vascular homeostasis. The work clarifies mechanisms of diabetic retinopathy and other vascular eye diseases, supporting the development of targeted therapies for patients with vision-threatening diabetic retinal complications and vascular eye disease.
5. Adipose Stem Cells for Metabolic Diseases: Mechanisms and Clinical Translation
This review summarizes targeted strategies using adipose-derived stem cells for metabolic diseases, including obesity and diabetes, and discusses mechanisms and challenges in clinical translation. It guides researchers and clinicians seeking regenerative, cell-based approaches for patients with metabolic disorders such as diabetes and obesity.
6. CCN1, Neutrophil Extracellular Traps and Diabetic Retinopathy Leakage
This study showed that CCN1 promotes retinal leakage in diabetic retinopathy by inducing neutrophil stasis and neutrophil extracellular trap extrusion. CCN1 was found to be a potential biomarker, offering a target for early screening and treatment of patients with diabetic retinopathy and retinal vascular leakage.
  • Affiliated Hospital

Where Dr. Chen Yanming practices

Guangzhou

The Third Affiliated Hospital,Sun Yat-Sen University

Chinese name: 中山大学附属第三医院
The Third Affiliated Hospital of Sun Yat-sen University, a Grade-A tertiary hospital founded in 1971, excels in hepatology, neurology and immunology with 5 national key disciplines, 15 national key specialties, four campuses and nationally leading liver-disease care, serving over 12,000 daily outpatients.
Since 1971
55 years of care
2,000
Licensed beds
15
National key specialties
817
Licensed beds
View Hospital Profile
Appointments with this physician are booked through official hospital channels only, coordinated end-to-end by Orisene.
  • WHY INTERNATIONAL PATIENTS CHOOSE CHINA

Why patients travel to China for treatment

Six reasons international patients now put China on their shortlist — from internationally aligned clinical capability to the policy channels that make treatment here genuinely reachable.

Clinical capability at international standard

Chinese hospitals deliver internationally aligned protocols, performing vast volumes of advanced robotic, minimally invasive, and complex transplant surgeries annually. This massive clinical data and highly specialized workforce ensure world-class outcomes, even for rare and complex cases.

Diagnostics and treatment in days, not months

A full medical workup that typically means months of waiting elsewhere is completed in China within 48–72 hours. Imaging, labs, and multidisciplinary consultations are integrated into a single visit, allowing treatment to commence immediately.

Transparent, itemised pricing

Chinese healthcare offers legally binding, itemised cost estimates before treatment begins, eliminating hidden fees or surprise billing. Due to national centralized procurement, total expenses remain 40–70% lower than comparable care in Western Europe or North America.

Policy channels that open the door

China facilitates access through 240-hour visa-free transit and dedicated medical visa routes. Policies like the Greater Bay Area drug pathway and Boao Lecheng’s pilot zone allow designated hospitals to administer innovative therapies not yet globally approved.
  • International Patient Guide

Consulting this physician, step by step

From the first message to the follow-up after you fly home, one coordinator, no paperwork on your side.
01
Day 0
  • Share your story
    A private consultation with an Orisene advisor, by message, phone or video. Send medical records in any language. Nothing is shared with the hospital yet.
02
Days 1–3
  • Records review & matching
    Orisene translates and presents your case to the right specialist. The hospital returns a tailored care plan, with costs itemised once that plan is confirmed.
03
Days 3–7
  • Your consultation
    Appointments are booked through official hospital channels only. Your navigator accompanies every visit with real-time interpretation, so you can focus on one thing: being cared for.
04
After you fly home
  • Reports & follow-up
    Translated reports and prescriptions delivered within days, remote follow-up coordination with your physicians at home, and a standing line to your navigator.
Orisene offers English and multilingual services, a professional medical interpreter at every consultation, plus translation of your records, reports and prescriptions.

Ready to plan your consultation with Dr. Chen Yanming?

Send your records in any language. An Orisene advisor will reply within 2 hours, present your case to the right specialist, and return a tailored care plan with itemised costs, before anything is booked. Simple. Private. Efficient.
Contact

Confidential, permanently

Independent — no hospital commission

We never handle medical fees

Information Sources

This physician profile is compiled by the Orisene team from publicly available online sources and verified at the time of publication. Details may change, and physician availability is confirmed at the time of booking.

Disclaimer: This information is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for personal medical guidance.

Mention of any specific product, brand, or manufacturer is for informational purposes only and does not constitute an endorsement or recommendation by Dr. Chen Yanming.